Methods for thrombolytic therapy
US5188830A · kind A · utility
10Cited by
3References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 2, 1990 |
| Grant date | Feb 23, 1993 |
| Priority date | — |
| Expiry date | Apr 2, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21068
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Certain Factor XIIIa inhibitor compounds have been discovered which have been found to be useful in the lysis of blood clots and thus adaptable for administration in thrombolytic therapy either alone or together with plasminogen activator.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.